OS Therapies Incorporated
OSTX
$2.00
$0.189.89%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.10M | 1.23M | 383.20K | 268.40K | 138.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.97M | 2.44M | 779.80K | 630.20K | 1.16M |
| Operating Income | -2.97M | -2.44M | -779.80K | -630.20K | -1.16M |
| Income Before Tax | -2.99M | -2.88M | -1.56M | -1.46M | -1.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.99M | -2.88M | -1.56M | -1.46M | -1.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.99M | -2.88M | -1.56M | -1.46M | -1.46M |
| EBIT | -2.97M | -2.44M | -779.80K | -630.20K | -1.16M |
| EBITDA | -2.97M | -2.44M | -779.10K | -629.50K | -1.16M |
| EPS Basic | -0.23 | -0.18 | -0.26 | -0.13 | -0.14 |
| Normalized Basic EPS | -0.09 | -0.11 | -0.16 | -0.08 | -0.09 |
| EPS Diluted | -0.23 | -0.18 | -0.26 | -0.13 | -0.14 |
| Normalized Diluted EPS | -0.09 | -0.11 | -0.16 | -0.08 | -0.09 |
| Average Basic Shares Outstanding | 21.76M | 15.90M | 5.99M | 11.41M | 10.68M |
| Average Diluted Shares Outstanding | 21.76M | 15.90M | 5.99M | 11.41M | 10.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |